Rigel Pharmaceuticals
RIGL
#6158
Rank
ยฃ0.66 B
Marketcap
ยฃ36.69
Share price
3.25%
Change (1 day)
83.82%
Change (1 year)

Earnings for Rigel Pharmaceuticals (RIGL)

Earnings in 2025 (TTM): ยฃ91.03 Million

According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are ยฃ0.28 Billion. In 2024 the company made an earning of ยฃ19.71 Million, an increase over its 2023 earnings that were of -ยฃ13.67 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rigel Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) ยฃ91.03 M361.75%
2024 ยฃ19.71 M-244.27%
2023 -ยฃ13.67 Million-66.79%
2022 -ยฃ41.16 Million340.73%
2021 -ยฃ9.34 Million-56.15%
2020 -ยฃ21.3 Million-57.34%
2019 -ยฃ49.93 Million-7.66%
2018 -ยฃ54.07 Million-9.47%
2017 -ยฃ59.72 Million24.46%
2016 -ยฃ47.99 Million23.63%
2015 -ยฃ38.82 Million-43.29%
2014 -ยฃ68.45 Million2.5%
2013 -ยฃ66.78 Million
2010 ยฃ28.39 M-133.97%
2009 -ยฃ83.59 Million-18.49%
2008 -ยฃ0.11 Billion71.91%
2007 -ยฃ59.66 Million84.74%
2006 -ยฃ32.29 Million-10.17%
2005 -ยฃ35.95 Million-15.73%
2004 -ยฃ42.66 Million39.29%
2003 -ยฃ30.63 Million10.3%
2002 -ยฃ27.77 Million48.3%
2001 -ยฃ18.73 Million-2.13%
2000 -ยฃ19.14 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ChemoCentryx
CCXI
-ยฃ97.97 Million-207.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-ยฃ81.78 Million-189.43%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ9.81 B 10,637.34%๐Ÿ‡ฌ๐Ÿ‡ง UK
Amgen
AMGN
ยฃ6.18 B 6,662.31%๐Ÿ‡บ๐Ÿ‡ธ USA